mounjaro tirzepatide patent expiry us The Tale of Two Drugs: Amid the weight-loss drug frenzy, the India heads of Eli Lilly and Novo Nordisk — makers of the world's most coveted obesity drugs — lay out their mounjaro patent expiration tirzepatide patent

Understanding these mechanisms helps clinicians and patients develop targeted management strategies for gastrointestinal symptoms that may arise during treatment

Statistical methods for detecting differentially abundant features in clinical metagenomic samples

N-acetyl-l-cysteine averts ferroptosis by fostering glutathione peroxidase 4

Benefits depend on candidacy, dosing, and consistency, and they are evaluated with lab work over time

HHS has announced that GHK-Cu is expected to return to Category 1, which would restore the compounding pathway for injectable formulations. BPC-157 On July 23, 2026, PCAC voted to recommend adding BPC-157 to the 503A Bulk Drug Substances List